517 related articles for article (PubMed ID: 30126717)
1. Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis.
Farzanegan A; Roudbary M; Falahati M; Khoobi M; Gholibegloo E; Farahyar S; Karimi P; Khanmohammadi M
J Mycol Med; 2018 Dec; 28(4):628-636. PubMed ID: 30126717
[TBL] [Abstract][Full Text] [Related]
2. Antifungal effects of indolicidin-conjugated gold nanoparticles against fluconazole-resistant strains of
Rahimi H; Roudbarmohammadi S; Delavari H H; Roudbary M
Int J Nanomedicine; 2019; 14():5323-5338. PubMed ID: 31409990
[No Abstract] [Full Text] [Related]
3. Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis.
Shi J; Li S; Gao A; Zhu K; Zhang H
Phytomedicine; 2018 Jul; 46():21-31. PubMed ID: 30097119
[TBL] [Abstract][Full Text] [Related]
4. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
Shokri H; Sharifzadeh A
J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis.
Rossi DC; Muñoz JE; Carvalho DD; Belmonte R; Faintuch B; Borelli P; Miranda A; Taborda CP; Daffre S
BMC Microbiol; 2012 Mar; 12():28. PubMed ID: 22394555
[TBL] [Abstract][Full Text] [Related]
6. Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model.
Khodavandi A; Alizadeh F; Harmal NS; Sidik SM; Othman F; Sekawi Z; Jahromi MA; Ng KP; Chong PP
FEMS Microbiol Lett; 2011 Feb; 315(2):87-93. PubMed ID: 21204918
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans.
de Sá NP; de Paula LFJ; Lopes LFF; Cruz LIB; Matos TTS; Lino CI; de Oliveira RB; de Souza-Fagundes EM; Fuchs BB; Mylonakis E; Johann S
J Glob Antimicrob Resist; 2018 Sep; 14():287-293. PubMed ID: 29715565
[TBL] [Abstract][Full Text] [Related]
8. Enhanced efficacy of synergistic combinations of antimicrobial peptides with caspofungin versus Candida albicans in insect and murine models of systemic infection.
MacCallum DM; Desbois AP; Coote PJ
Eur J Clin Microbiol Infect Dis; 2013 Aug; 32(8):1055-62. PubMed ID: 23572153
[TBL] [Abstract][Full Text] [Related]
9. Graphene oxide nanosheets increase Candida albicans killing by pro-inflammatory and reparative peritoneal macrophages.
Diez-Orejas R; Feito MJ; Cicuéndez M; Casarrubios L; Rojo JM; Portolés MT
Colloids Surf B Biointerfaces; 2018 Nov; 171():250-259. PubMed ID: 30036792
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.
Petraitiene R; Petraitis V; Groll AH; Candelario M; Sein T; Bell A; Lyman CA; McMillian CL; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 1999 Sep; 43(9):2148-55. PubMed ID: 10471556
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.
Kamai Y; Kakuta M; Shibayama T; Fukuoka T; Kuwahara S
Antimicrob Agents Chemother; 2005 Jan; 49(1):52-6. PubMed ID: 15616275
[TBL] [Abstract][Full Text] [Related]
12. Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro.
Harris MR; Coote PJ
Int J Antimicrob Agents; 2010 Apr; 35(4):347-56. PubMed ID: 20106636
[TBL] [Abstract][Full Text] [Related]
13. The antifungal activity of graphene oxide-silver nanocomposites.
Li C; Wang X; Chen F; Zhang C; Zhi X; Wang K; Cui D
Biomaterials; 2013 May; 34(15):3882-90. PubMed ID: 23465487
[TBL] [Abstract][Full Text] [Related]
14. Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence.
Sun W; Wang D; Yu C; Huang X; Li X; Sun S
Int J Antimicrob Agents; 2017 Sep; 50(3):399-405. PubMed ID: 28673609
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of T-2307, a novel arylamidine, against ocular complications of disseminated candidiasis in mice.
Abe M; Nakamura S; Kinjo Y; Masuyama Y; Mitsuyama J; Kaku M; Miyazaki Y
J Antimicrob Chemother; 2019 May; 74(5):1327-1332. PubMed ID: 30753506
[TBL] [Abstract][Full Text] [Related]
16. Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.
Ng SM; Yap YY; Cheong JW; Ng FM; Lau QY; Barkham T; Teo JW; Hill J; Chia CS
J Pept Sci; 2017 Mar; 23(3):215-221. PubMed ID: 28105725
[TBL] [Abstract][Full Text] [Related]
17. Chitosan silver nanocomposite (CAgNC) as an antifungal agent against Candida albicans.
Kulatunga D; Dananjaya S; Godahewa GI; Lee J; De Zoysa M
Med Mycol; 2017 Feb; 55(2):213-222. PubMed ID: 27495320
[TBL] [Abstract][Full Text] [Related]
18. In vivo imaging of disseminated murine Candida albicans infection reveals unexpected host sites of fungal persistence during antifungal therapy.
Jacobsen ID; Lüttich A; Kurzai O; Hube B; Brock M
J Antimicrob Chemother; 2014 Oct; 69(10):2785-96. PubMed ID: 24951534
[TBL] [Abstract][Full Text] [Related]
19. Difference in virulence between fluconazole-susceptible and fluconazole-resistant Candida albicans in a mouse model.
Schulz B; Weber K; Schmidt A; Borg-von Zepelin M; Ruhnke M
Mycoses; 2011 Sep; 54(5):e522-30. PubMed ID: 21605180
[TBL] [Abstract][Full Text] [Related]
20. The in vitro, in vivo antifungal activity and the action mode of Jelleine-I against Candida species.
Jia F; Wang J; Peng J; Zhao P; Kong Z; Wang K; Yan W; Wang R
Amino Acids; 2018 Feb; 50(2):229-239. PubMed ID: 29101485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
